BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17766722)

  • 1. 'Increased incidence of secondary tumours in thyroid cancer patients': a fact or a sophism?
    Mayr A; Füger B; Staudenherz A
    Eur J Endocrinol; 2007 Sep; 157(3):369. PubMed ID: 17766722
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid cancer as second primary malignancy in breast cancer patients.
    Sioka C; Fotopoulos A
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1604; author reply 1604. PubMed ID: 19306760
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database.
    Kuo JH; Chabot JA; Lee JA
    Surgery; 2016 Jan; 159(1):23-9. PubMed ID: 26522696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sonographic diagnosis of secondary blastomas of the thyroid gland].
    Binder A; Hermann M; Schratter M
    Rofo; 1994 Apr; 160(4):299-302. PubMed ID: 8161741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of second primary malignancies in thyroid cancer patients.
    Okere PC; Olusina DB; Shamim SA; Shandra V; Tushar M; Sellam K; Bal C
    Niger J Clin Pract; 2013; 16(1):96-9. PubMed ID: 23377480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies.
    Van Fossen VL; Wilhelm SM; Eaton JL; McHenry CR
    Ann Surg Oncol; 2013 Apr; 20(4):1341-7. PubMed ID: 23263698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
    Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
    Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peculiarities of synchronic and metachronous malignant tumors of reproductive system in thyroid gland cancer.
    Makaridze T; Mardaleishvili K
    Georgian Med News; 2009 Dec; (177):44-7. PubMed ID: 20090152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion.
    Surgery; 2016 Jan; 159(1):29-30. PubMed ID: 26522698
    [No Abstract]   [Full Text] [Related]  

  • 11. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
    Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
    J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary cancers: Incidence, risk factors and recommendations].
    Demoor-Goldschmidt C; Fayech C; Girard P; Plantaz D
    Bull Cancer; 2015; 102(7-8):656-64. PubMed ID: 25911942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of second primary malignancy in patients with thyroid cancer.
    Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
    QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonendocrine cancers associated with benign and malignant parathyroid tumors.
    Fallah M; Kharazmi E; Sundquist J; Hemminki K
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1108-14. PubMed ID: 21525164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of secondary primary malignancy in early stage differentiated thyroid cancer: a US population-based study.
    Uprety D; Khanal A; Arjyal L; Bista A; Basnet B; Kandel P; Gogireddy TR; Adhikari J
    Acta Oncol; 2016 Nov; 55(11):1375-1377. PubMed ID: 27579851
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple primary thyroid and breast cancer in Israel, 1960-1976.
    Stein M; Bartal A; Kuten A; Loberant N; Hershkovitz R; Masalcha H; Robinson E
    S Afr Med J; 1989 Dec; 76(12):664-6. PubMed ID: 2595504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.